Sign inJoin waitlistJoin the waitlist

Joshua Hare

Director, Donald Soffer Endowed Program in Regenerative Medicine, Cardiovascular Medicine · University of Miami/Jackson Health System

Credentials: · · · · · · ·

History

University of Miami/Jackson Health System
Present
Interdisciplinary Stem Cell Institute Center · University of Miami/Jackson Health System
Present
Interdisciplinary Stem Cell Institute Center · Jackson Memorial Hospital
Present

Brigham and Women's Hospital
1998–1999
Cardiovascular Disease
University of Miami/Jackson Health System
1995–1998
Advanced Heart Failure and Transplant Cardiology
University of Miami/Jackson Health System
1994–1995
Johns Hopkins Hospital
1991–1994
Boston Children's Hospital
1988–1991
Johns Hopkins School of Medicine
1984–1988
University
1980–1984

Research

FGF23 induces left ventricular hypertrophy
Journal of Clinical Investigation · 2011 · 1,632 citations
Mesenchymal stem cell perspective: cell biology to clinical progress
Review · npj Regenerative Medicine · 2019 · 1,506 citations
Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy
New England Journal of Medicine · 2000 · 1,208 citations

IS
Ivonne Schulman
42 papers
AH
Alan Heldman
30 papers
KB
Kenneth Baughman
22 papers
Roberto Bolli
21 papers
DK
David Kass
20 papers
Ed Kasper
20 papers
KS
Karl Schuleri
17 papers
Raul Mitrani
17 papers
Dan Berkowitz
16 papers
Lili Barouch
16 papers · 5 as a fellow
Michelle Kittleson
16 papers · 10 as a fellow
HC
Hunter Champion
15 papers · 3 as a fellow

Grants

Full-Scale GMP Production for a Pre-Clinical Systemic Delivered Mesenchymal Stem Cells Derived Extracellular Vesicles For Cardiovascular Disease
National Heart, Lung, and Blood Institute · U01
Contact PI · $502.2K · University of Miami School of Medicine
2023–2027
1/2 Allogeneic Human Mesenchymal Stem Cell (MSC) Injection in Patients with Hypoplastic Left Heart Syndrome: A Phase IIb Clinical Trial
National Heart, Lung, and Blood Institute · UH3
PI · $3.5M · Lurie Children's Hospital of Chicago
2020–2026
Mesenchymal Stem Cell Therapy for Endothelial Dysfunction in Diabetes
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.2M · University of Miami School of Medicine
2016–2024
A Phase 2b Clinical Trial to Study the Efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) to Treat Aging Frailty
National Institute on Aging · R44
PI · $4.2M · Longeveron, Llc
2018–2021

Clinical trials

The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial.
Principal investigator · Withdrawn · Phase 1, Phase 2
Joshua M Hare
2025–2032
Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19
Principal investigator · Withdrawn · Phase 1
Joshua M Hare
2022–2024
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
Principal investigator · Recruiting · Phase 2
Joshua M Hare
2021–2027
Infusion of Umbilical Cord Versus Bone Marrow Derived Mesenchymal Stem Cells to Evaluate Cytokine Suppression.
Principal investigator · Terminated · Phase 1, Phase 2
Joshua M Hare
2018–2021